Clinical utility of a pediatric hand exoskeleton: identifying users, practicability, and acceptance, and recommendations for design improvement.

Acceptability Appropriateness Bimanual performance Disability Hand function Pediatric neurorehabilitation Practicability Wearable robots

Journal

Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233

Informations de publication

Date de publication:
11 02 2022
Historique:
received: 26 08 2021
accepted: 21 01 2022
entrez: 12 2 2022
pubmed: 13 2 2022
medline: 22 3 2022
Statut: epublish

Résumé

Children and adolescents with upper limb impairments can experience limited bimanual performance reducing daily-life independence. We have developed a fully wearable pediatric hand exoskeleton (PEXO) to train or compensate for impaired hand function. In this study, we investigated its appropriateness, practicability, and acceptability. Children and adolescents aged 6-18 years with functional limitations in at least one hand due to a neurological cause were selected for this cross-sectional evaluation. We characterized participants by various clinical tests and quantified bimanual performance with the Assisting Hand Assessment (AHA). We identified children whose AHA scaled score increased by ≥ 7 points when using the hand exoskeleton and determined clinical predictors to investigate appropriateness. The time needed to don each component and the number of technical issues were recorded to evaluate practicability. For acceptability, the experiences of the patients and the therapist with PEXO were evaluated. We further noted any adverse events. Eleven children (median age 11.4 years) agreed to participate, but data was available for nine participants. The median AHA scaled score was higher with PEXO (68; IQR: 59.5-83) than without (55; IQR: 37.5-80.5; p = 0.035). The Box and Block test, the Selective Control of the Upper Extremity Scale, and finger extensor muscle strength could differentiate well between those participants who improved in AHA scaled scores by ≥ 7 points and those who did not (sensitivity and specificity varied between 0.75 and 1.00). The median times needed to don the back module, the glove, and the hand module were 62, 150, and 160 s, respectively, but all participants needed assistance. The most critical failures were the robustness of the transmission system, the electronics, and the attachment system. Acceptance was generally high, particularly in participants who improved bimanual performance with PEXO. Five participants experienced some pressure points. No adverse events occurred. PEXO is a safe exoskeleton that can improve bimanual hand performance in young patients with minimal hand function. PEXO receives high acceptance. We formulated recommendations to improve technical issues and the donning before such exoskeletons can be used under daily-life conditions for therapy or as an assistive device. Trial registration Not appropriate.

Sections du résumé

BACKGROUND
Children and adolescents with upper limb impairments can experience limited bimanual performance reducing daily-life independence. We have developed a fully wearable pediatric hand exoskeleton (PEXO) to train or compensate for impaired hand function. In this study, we investigated its appropriateness, practicability, and acceptability.
METHODS
Children and adolescents aged 6-18 years with functional limitations in at least one hand due to a neurological cause were selected for this cross-sectional evaluation. We characterized participants by various clinical tests and quantified bimanual performance with the Assisting Hand Assessment (AHA). We identified children whose AHA scaled score increased by ≥ 7 points when using the hand exoskeleton and determined clinical predictors to investigate appropriateness. The time needed to don each component and the number of technical issues were recorded to evaluate practicability. For acceptability, the experiences of the patients and the therapist with PEXO were evaluated. We further noted any adverse events.
RESULTS
Eleven children (median age 11.4 years) agreed to participate, but data was available for nine participants. The median AHA scaled score was higher with PEXO (68; IQR: 59.5-83) than without (55; IQR: 37.5-80.5; p = 0.035). The Box and Block test, the Selective Control of the Upper Extremity Scale, and finger extensor muscle strength could differentiate well between those participants who improved in AHA scaled scores by ≥ 7 points and those who did not (sensitivity and specificity varied between 0.75 and 1.00). The median times needed to don the back module, the glove, and the hand module were 62, 150, and 160 s, respectively, but all participants needed assistance. The most critical failures were the robustness of the transmission system, the electronics, and the attachment system. Acceptance was generally high, particularly in participants who improved bimanual performance with PEXO. Five participants experienced some pressure points. No adverse events occurred.
CONCLUSIONS
PEXO is a safe exoskeleton that can improve bimanual hand performance in young patients with minimal hand function. PEXO receives high acceptance. We formulated recommendations to improve technical issues and the donning before such exoskeletons can be used under daily-life conditions for therapy or as an assistive device. Trial registration Not appropriate.

Identifiants

pubmed: 35148786
doi: 10.1186/s12984-022-00994-9
pii: 10.1186/s12984-022-00994-9
pmc: PMC8832660
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17

Informations de copyright

© 2022. The Author(s).

Références

IEEE Trans Neural Syst Rehabil Eng. 2020 Jun;28(6):1407-1415
pubmed: 32305931
IEEE Int Conf Rehabil Robot. 2019 Jun;2019:108-114
pubmed: 31374615
Arch Phys Med Rehabil. 2009 May;90(5):849-55
pubmed: 19406307
IEEE Int Conf Rehabil Robot. 2013 Jun;2013:6650500
pubmed: 24187315
Int J Qual Health Care. 2006 Oct;18(5):377-82
pubmed: 16951425
Am J Occup Ther. 2013 May-Jun;67(3):312-8
pubmed: 23597689
J Hand Ther. 2020 Apr - Jun;33(2):198-208
pubmed: 32423846
Stroke. 2005 Jun;36(6):1172-7
pubmed: 15890987
J Perianesth Nurs. 2001 Feb;16(1):35-40
pubmed: 11266644
Phys Ther. 2014 May;94(5):609-22
pubmed: 24415772
Res Dev Disabil. 2011 Nov-Dec;32(6):2283-94
pubmed: 21862283
Curr Neurol Neurosci Rep. 2020 Feb 21;20(2):3
pubmed: 32086598
J Neuroeng Rehabil. 2018 Jun 28;15(1):59
pubmed: 29954401
Front Robot AI. 2021 Jan 28;7:596185
pubmed: 33585573
Biomimetics (Basel). 2018 Jul 18;3(3):
pubmed: 31105239
Dev Med Child Neurol. 2016 Jun;58(6):618-24
pubmed: 26507383
Dev Med Child Neurol. 2006 Jul;48(7):549-54
pubmed: 16780622
J Neuroeng Rehabil. 2018 Feb 17;15(1):9
pubmed: 29454392
J Vis Exp. 2020 May 20;(159):
pubmed: 32510515
Am J Occup Ther. 1986 Oct;40(10):705-11
pubmed: 3777107
J Child Neurol. 2017 Jan;32(1):132-138
pubmed: 27742862
J Rehabil Med. 2018 Jul 17;50(7):598-606
pubmed: 30003268
IEEE Trans Biomed Circuits Syst. 2019 Dec;13(6):1351-1361
pubmed: 31670679
Soft Robot. 2021 Apr;8(2):128-143
pubmed: 32552422
Disabil Rehabil. 2010;32(5):409-16
pubmed: 20095955
Stroke. 2007 Mar;38(3):1088-90
pubmed: 17255546
Gait Posture. 2019 Mar;69:176-186
pubmed: 30769260
J Neuroeng Rehabil. 2020 Feb 26;17(1):33
pubmed: 32102668
IEEE Int Conf Rehabil Robot. 2019 Jun;2019:1073-1078
pubmed: 31374772
Dev Med Child Neurol. 2016 Jun;58(6):612-7
pubmed: 26526592
Arch Phys Med Rehabil. 1997 Dec;78(12):1309-15
pubmed: 9421983
Pediatrics. 2006 Nov;118(5):2159-67
pubmed: 17079590
Stroke. 2010 Apr;41(4):745-50
pubmed: 20167916
Semin Plast Surg. 2016 Feb;30(1):14-23
pubmed: 26869859
IEEE Int Conf Rehabil Robot. 2017 Jul;2017:615-621
pubmed: 28813888

Auteurs

Jan Lieber (J)

Swiss Children's Rehab - Research Department, University Children's Hospital Zurich, Mühlebergstrasse 104, CH-8910, Affoltern am Albis, Switzerland.
Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland.

Jan Dittli (J)

Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, 8008, Zurich, Switzerland.

Olivier Lambercy (O)

Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, 8008, Zurich, Switzerland.

Roger Gassert (R)

Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, 8008, Zurich, Switzerland.

Andreas Meyer-Heim (A)

Swiss Children's Rehab - Research Department, University Children's Hospital Zurich, Mühlebergstrasse 104, CH-8910, Affoltern am Albis, Switzerland.
Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland.

Hubertus J A van Hedel (HJA)

Swiss Children's Rehab - Research Department, University Children's Hospital Zurich, Mühlebergstrasse 104, CH-8910, Affoltern am Albis, Switzerland. Hubertus.vanhedel@kispi.uzh.ch.
Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland. Hubertus.vanhedel@kispi.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH